AgomAb Therapeutics NV (AGMB)
10.51
-0.05
(-0.47%)
USD |
NASDAQ |
May 19, 16:00
10.50
-0.02
(-0.14%)
After-Hours: 20:00
AgomAb Therapeutics Enterprise Value : 382.23M for May 19, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| UCB SA | -- |
| AstraZeneca PLC | 312.64B |
| ANI Pharmaceuticals, Inc. | 2.114B |
| Corcept Therapeutics, Inc. | 5.921B |
| Assertio Holdings, Inc. | 118.96M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -20.25M |
| Total Expenses (Quarterly) | 20.25M |
| EPS Diluted (Quarterly) | -0.4156 |
| Earnings Yield | -6.40% |